SB1067: Ensuring Timely Access to Generics Act of 2023
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions.
Plain-language summary
This bill would change how citizen petitions work under federal drug law. Citizen petitions are formal requests that anyone can submit to the Food and Drug Administration asking it to take or not take certain actions on drugs. The bill aims to speed up the process for generic drugs to reach the market. It has been introduced in Congress and is in the early legislative stage. The bill is sponsored by senators from both political parties.
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
SB1067: Ensuring Timely Access to Generics Act of 2023
Upcoming hearings & events
Sponsors
Jeanne Shaheen
Primary SponsorCo-sponsors (5)
Susan Collins
Michael Bennet
Marco Rubio
Tammy Baldwin
Mike Braun